Related Experiment Video
Updated: Aug 19, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Cromolyn sodium in the treatment of children with asthma
Insights
Cromolyn sodium effectively managed chronic asthma in 80% of children, significantly reducing or eliminating the need for steroid medications. This asthma treatment offers a promising alternative for pediatric patients.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Chronic asthma in children presents significant management challenges.
- Steroid dependence is a common concern in pediatric asthma care.
- Alternative therapeutic options are continuously sought for long-term asthma control.
Purpose of the Study:
- To evaluate the efficacy of cromolyn sodium in managing chronic, intractable asthma in pediatric patients.
- To assess the impact of cromolyn sodium on steroid requirements in children with asthma.
Main Methods:
- A cohort of fifteen children with chronic, intractable asthma was treated with cromolyn sodium.
- Patient outcomes and steroid dosages were monitored throughout the treatment period.
Main Results:
- Overall improvement was observed in 80% of the pediatric patients treated with cromolyn sodium.
- A significant reduction or complete elimination of steroid requirement was noted in a substantial proportion of patients.
- Cromolyn sodium demonstrated a favorable safety profile in this pediatric cohort.
Conclusions:
- Cromolyn sodium is an effective therapeutic agent for managing chronic, intractable asthma in children.
- The drug shows potential in reducing or eliminating the need for corticosteroid therapy, thereby mitigating associated side effects.
- Further research into long-term efficacy and broader application in pediatric asthma management is warranted.
Abstract:
We have reported our experience with cromolyn sodium in the management of fifteen children with chronic, intractable asthma. The overall improvement in 80% of children is in accordance with some of the studies reported in the literature. The most significant effect of the drug was in either reducing the dose of steroid needed for management or eliminating its requirement by the patient.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

